Consumer Health COVID19
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...
February 21, 2022 | News
TGA Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...
February 18, 2022 | News
Singapore brand Buzud unveils High Flow Nasal Cannula developed to speed up COVID-19 patients’ recovery
The BUZUD HFNC is approved by Singapore’s Health Sciences Authority (HSA) and provides adequately heated and humidified respiratory gases to spontane...
February 16, 2022 | News
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 15, 2022 | News
Pluslife Biotech Launches First Handheld Covid-19 Nucleic Acid Test
Hong Kong has been severely hit by the latest wave of COVID-19 infections in recent weeks. In response to challenges including the lack of manpower fo...
February 15, 2022 | News
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
- Seegene to sign a contract with the Brazilian government to supply 4 million COVID-19 tests and associated consumables - 'Allplex™ SARS-CoV-2/FluA...
February 14, 2022 | News
Kintor Pharma Announces First Patient Dosing in China
Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...
February 14, 2022 | News
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 04, 2022 | News
Novavax Submits Request to the U.S. FDA for EUA of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 01, 2022 | News
Australia approves Pfizer booster for 16–17 year olds
The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old. The adv...
January 31, 2022 | News
Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022
Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) f...
January 31, 2022 | News
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test
PHASE Scientific International LTD (PHASE Scientific), today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID&...
January 27, 2022 | News
Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets
Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will ...
January 20, 2022 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
